Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coats

Showing results (291-300 of 402) with videos related to

Pageof 41
Sort By:
International Journal of Cardiology|July 1, 2026
Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countriesGiuseppe Ambrosio, Luis Henrique Wolff Gowdak, Richard B Weiskopf, et al.
European Journal of Immunology|June 22, 2016
TSLP or IL-7 provide an IL-7Rα signal that is critical for human B lymphopoiesisTerry-Ann M Milford, Ruijun J Su, Olivia L Francis, et al.
European Journal of Heart Failure|April 4, 2020
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainscak, Maria G Crespo-Leiro, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
ESC Heart Failure|July 4, 2020
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term RegistryAgnieszka Kapłon-Cieślicka, Cécile Laroche, Maria G Crespo-Leiro, et al.
International Journal of Cardiology|September 16, 2016
The effectiveness of Dietary Approaches to Stop Hypertension (DASH) counselling on estimated 10-year cardiovascular risk among patients with newly diagnosed grade 1 hypertension: A randomised clinical trialMartin C S Wong, Harry H X Wang, Mandy W M Kwan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Journal of Heart Failure|December 30, 2021
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Rudolf A de Boer, Stephane Heymans, Johannes Backs, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Pageof 41

Showing results (291-300 of 402) with videos related to

Sort By:
Pageof 41
International Journal of Cardiology|July 1, 2026
Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countriesGiuseppe Ambrosio, Luis Henrique Wolff Gowdak, Richard B Weiskopf, et al.
European Journal of Immunology|June 22, 2016
TSLP or IL-7 provide an IL-7Rα signal that is critical for human B lymphopoiesisTerry-Ann M Milford, Ruijun J Su, Olivia L Francis, et al.
European Journal of Heart Failure|April 4, 2020
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainscak, Maria G Crespo-Leiro, et al.
European Heart Journal|December 19, 2025
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trialJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
ESC Heart Failure|July 4, 2020
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term RegistryAgnieszka Kapłon-Cieślicka, Cécile Laroche, Maria G Crespo-Leiro, et al.
International Journal of Cardiology|September 16, 2016
The effectiveness of Dietary Approaches to Stop Hypertension (DASH) counselling on estimated 10-year cardiovascular risk among patients with newly diagnosed grade 1 hypertension: A randomised clinical trialMartin C S Wong, Harry H X Wang, Mandy W M Kwan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Journal of Heart Failure|December 30, 2021
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Rudolf A de Boer, Stephane Heymans, Johannes Backs, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Pageof 41